EIF2AK4 and Charcot-Marie-Tooth disease type 2D: Additionally, as for CMT2D mice, activation of the ISR was detected in homozygous Yars1E196K mice, however the therapeutic benefit of GCN2 inhibition is yet to be tested in this model (Spaulding et al., 2021).